Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Semiautomatic VWF Multimer Densitometric Analysis: Validation of the Clinical Accuracy and Clinical Implications in Von Willebrand Disease

Ferdows Atiq, Johan Boender, MD, Marjon H. Cnossen, MD PhD, Johanna G van der Bom, MD PhD, Karin Fijnvandraat, MD PhD, Joke de Meris, Moniek P.M. de Maat, PhD, Karin P.M. Van Galen, MD MSc, PhD, Britta A.P. Laros-Van Gorkom, MD PhD, Karina Meijer, MD PhD, Jeroen C.J. Eikenboom, MD PhD, Frank W.G. Leebeek, MD PhD

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-142287

Published: 2020

Journal Articles

Silent Cerebral Infarcts in Sickle Cell Disease: A Systematic Review

Maite E. Houwing, MD, Rowena Grohssteiner, BSc, Anne P.J. de Pagter, MD PhD, Karin Fijnvandraat, MD PhD, Jaap Oosterlaan, Lotte Haverman, Marjolein Dremmen, Tonya White, Marjon H. Cnossen, MD PhD

Blood (2019) 134 (Supplement_1): 4836.

https://doi.org/10.1182/blood-2019-130165

Published: 2019

Journal Articles

Genetic Association Studies of Red Blood Cell Transfusion Related Alloimmunization: A Systematic Review and Meta-Analysis

Jorn Gerritsma, MD, Ilja Oomen, BSc, Sanne Meinderts, PhD, C. Ellen van der Schoot, MD PhD, Bart J. Biemond, MD PhD, Johanna G van der Bom, MD PhD, Karin Fijnvandraat, MD PhD

Blood (2019) 134 (Supplement_1): 2459.

https://doi.org/10.1182/blood-2019-128199

Published: 2019

Journal Articles

The Oxygenscan Provides Clinically Relevant Biomarkers for Treatment Efficacy That Are Associated with Frequency of Vaso-Occlusive Crisis in Sickle Cell Disease

Minke A.E. Rab, MD, Richard van Wijk, PhD, Celeste K. Kanne, BA, Brigitte A. van Oirschot, Jennifer Bos, Camille Boisson, Maite E. Houwing, MD, Jorn J. Gerritsma, MD, Karin Fijnvandraat, MD PhD, Celine Renoux, PhD, Marije Bartels, MD PhD, Erfan Nur, MD PhD, Marjon H. Cnossen, MD PhD, Philippe Joly, PhD, Romain Fort, MD, Philippe Connes, PhD, Eduard J. van Beers, MD PhD, Vivien A. Sheehan, MD PhD

Blood (2019) 134 (Supplement_1): 2275.

https://doi.org/10.1182/blood-2019-128870

Published: 2019

Journal Articles

Effects of Oral N -Acetylcysteine on Oxidative Stress in Patients with Sickle Cell Disease

Blood (2017) 130 (Supplement 1): 2244.

https://doi.org/10.1182/blood.V130.Suppl_1.2244.2244

Published: 2017

Journal Articles

N-Acetylcysteine in Patients with Sickle Cell Disease: A Randomized Controlled Trial

Blood (2016) 128 (22): 123.

https://doi.org/10.1182/blood.V128.22.123.123

Published: 2016

Journal Articles

No Association Between Normalization of VWF Levels and Bleeding Phenotype in Patients with Type 1 VWD - from the Win Study

Johan Boender, MD, Jeroen Eikenboom, MD PhD, Karin Fijnvandraat, MD PhD, Waander van Heerde, PhD, Karina Meijer, MD PhD, Evelien Mauser-Bunschoten, MD PhD, Marjon Cnossen, MD PhD, Joke de Meris, Britta Laros-van Gorkom, MD PhD, Anske van der Bom, MD PhD, Frank W.G. Leebeek, MD PhD

Blood (2016) 128 (22): 2577.

https://doi.org/10.1182/blood.V128.22.2577.2577

Published: 2016

Journal Articles

Targeting Clotting Factor VIII Plasma Values in the Perioperative Setting in Hemophilia a: “Tackling a Moving Target” (“OPTI-CLOT” Studies)

Janske Lock, MD PhDstudent, Hendrika C.A.M. Hazendonk, MD PhDstudent, Ron A.A. Mathôt, Prof. Dr., Karina Meijer, MD PhD, Marjolein Peters, MD PhD, Paul Brons, Felix J.M. Van der Meer, MD PhD, Hannan Bouzariouh, MD, Mariette H.E. Driessens, PhD, Karin Fijnvandraat, MD PhD, Frank W.G. Leebeek, MD PhD, Marjon H. Cnossen, MD PhD

Blood (2014) 124 (21): 5031.

https://doi.org/10.1182/blood.V124.21.5031.5031

Published: 2014

Journal Articles

Towards Successful Implementation of Pharmacokinetic-Guided Prophylactic Dosing of Clotting Factor Concentrate in Hemophilia; The Do’s and Don’ts after Discrete Choice Experiment Analysis

Janske Lock, MD PhDstudent, Esther W. de Bekker-Grob, PhD, Gamze Urhan, MD, Saskia Middeldorp, MD PhD, Marjolein Peters, MD PhD, Karina Meijer, MD PhD, Rienk Y.J. Tamminga, MD PhD, Britta Laros-van Gorkum, MD PhD, Paul Brons, Felix J.M. Van der Meer, MD PhD, Mariette H.E. Driessens, PhD, Peter W. Collins, MD, Karin Fijnvandraat, MD PhD, Frank W.G. Leebeek, MD PhD, Marjon H. Cnossen, MD PhD

Blood (2014) 124 (21): 5038.

https://doi.org/10.1182/blood.V124.21.5038.5038

Published: 2014

Journal Articles

Volume of White Matter Hyperintensities Predicts Neurocognitive Functioning in Children with Sickle Cell Disease

Veronica Van Der Land, MD, Channa T. Hijmans, PhD, Marieke A. de Ruiter, Henri J.M.M. Mutsaerts, MD, Marjon H. Cnossen, MD PhD, Charles B.L.M. Majoie, MD PhD, Aart J. Nederveen, PhD, Martha A. Grootenhuis, PhD, Karin Fijnvandraat, MD PhD

Blood (2014) 124 (21): 2720.

https://doi.org/10.1182/blood.V124.21.2720.2720

Published: 2014

Journal Articles

Alloantibody Formation In Sickle Cell Disease

Joep Sins, MD, MSc, Saurabh Zalpuri, MD, PhD, Marjon Cnossen, MD, PhD, Anita W. Rijneveld, MD, PhD, Jean-Louis Kerkhoffs, MD, PhD, Alfred van Meurs, MD, Yolanda de Rijke, PhD, Marjolein Peters, MD, PhD, Bart J. Biemond, MD, PhD, Anske van der Bom, MD, PhD, Karin Fijnvandraat, MD, PhD

Blood (2013) 122 (21): 2395.

https://doi.org/10.1182/blood.V122.21.2395.2395

Published: 2013

Journal Articles

Pre-Operative Transfusion Reduces Serious Adverse Events in Patients with Sickle Cell Disease (SCD): Results From the Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) Randomised Controlled Multicentre Clinical Trial

Jo Howard, MB, BChir, MRCP, FRCPath, Moira Malfroy, RN, Llewelyn Charlotte, PhD, Louise Choo, PhD, David Rees, FRCPath, Isabeau Walker, FRCA, Tony Johnson, PhD, Louise Tillyer, FRCPath, Karin Fijnvandraat, MD, PhD, Melanie Kirby-Allen, MD, Renate Hodge, MSc, Shilpi Purohit, Sally C. Davies, FRCP, FMedSci, Lorna M Williamson, FRCPath

Blood (2011) 118 (21): 9.

https://doi.org/10.1182/blood.V118.21.9.9

Published: 2011

Journal Articles

Women with Moderate and Severe Von Willebrand Disease Have a High Morbidity of Gynecological and Obstetric Bleeding

Eva de Wee, MD, Marieke Knol, MD, Eveline Mauser-Bunschoten, MD, PhD, Anske van der Bom, PhD, Manon Degenaar-Dujardin, BA, Jeroen C.J. Eikenboom, MD, PhD, Karin Fijnvandraat, MD, PhD, Arja de Goede-Bolder, MD, Britta Laros-van Gorkom, MD, PhD, Paula Ypma, MD, Sonja Zweegman, Karina Meijer, MD, PhD, Frank W.G. Leebeek, MD, PhD

Blood (2010) 116 (21): 542.

https://doi.org/10.1182/blood.V116.21.542.542

Published: 2010

Journal Articles

Heart Function Disorders In Sickle Cell Disease

Charlotte Heinen, Karin Fijnvandraat, MD, PhD, Marjolein Peters, MD, PhD, Henriette Heijboer, MD, PhD, Nico Blom, MD, PhD, Irene Kuipers, MD, PhD

Blood (2010) 116 (21): 4815.

https://doi.org/10.1182/blood.V116.21.4815.4815

Published: 2010

Journal Articles

Measurement of Disease Severity in Patients with Sickle Cell Disease: A Systematic Review.

Xandra W. van den Tweel, MD, Johanna H. van der Lee, MD, Jo Howard, MD, Karin Fijnvandraat, MD, PhD, (Intr. by Marinus H.J. Van Oers )

Blood (2007) 110 (11): 2250.

https://doi.org/10.1182/blood.V110.11.2250.2250

Published: 2007

Journal Articles

Development and Validation of a Pediatric Severity Index for Sickle Cell Patients.

Xandra W. van den Tweel, MD, Johanna H. van der Lee, MD, Harriët Heijboer, MD PhD, Marjolein Peters, MD PhD, Karin Fijnvandraat, MD PhD

Blood (2007) 110 (11): 3391.

https://doi.org/10.1182/blood.V110.11.3391.3391

Published: 2007

NARROW

Semiautomatic VWF Multimer Densitometric Analysis: Validation of the Clinical Accuracy and Clinical Implications in Von Willebrand Disease

Silent Cerebral Infarcts in Sickle Cell Disease: A Systematic Review

Genetic Association Studies of Red Blood Cell Transfusion Related Alloimmunization: A Systematic Review and Meta-Analysis

The Oxygenscan Provides Clinically Relevant Biomarkers for Treatment Efficacy That Are Associated with Frequency of Vaso-Occlusive Crisis in Sickle Cell Disease

Effects of Oral N -Acetylcysteine on Oxidative Stress in Patients with Sickle Cell Disease

N-Acetylcysteine in Patients with Sickle Cell Disease: A Randomized Controlled Trial

No Association Between Normalization of VWF Levels and Bleeding Phenotype in Patients with Type 1 VWD - from the Win Study

Targeting Clotting Factor VIII Plasma Values in the Perioperative Setting in Hemophilia a: “Tackling a Moving Target” (“OPTI-CLOT” Studies)

Towards Successful Implementation of Pharmacokinetic-Guided Prophylactic Dosing of Clotting Factor Concentrate in Hemophilia; The Do’s and Don’ts after Discrete Choice Experiment Analysis

Volume of White Matter Hyperintensities Predicts Neurocognitive Functioning in Children with Sickle Cell Disease

Alloantibody Formation In Sickle Cell Disease

Pre-Operative Transfusion Reduces Serious Adverse Events in Patients with Sickle Cell Disease (SCD): Results From the Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) Randomised Controlled Multicentre Clinical Trial

Women with Moderate and Severe Von Willebrand Disease Have a High Morbidity of Gynecological and Obstetric Bleeding

Heart Function Disorders In Sickle Cell Disease

Measurement of Disease Severity in Patients with Sickle Cell Disease: A Systematic Review.

Development and Validation of a Pediatric Severity Index for Sickle Cell Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only